CoronaVac (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "CoronaVac" in Czech language version.

refsWebsite
Global rank Czech rank
49th place
92nd place
1st place
1st place
2nd place
4th place
5th place
3rd place
4th place
8th place
5,225th place
2,661st place
129th place
250th place
11th place
313th place
2,228th place
1,527th place
low place
low place
74th place
3,781st place
7th place
43rd place
79th place
324th place
362nd place
1,155th place
234th place
72nd place
195th place
168th place
low place
low place
1,722nd place
low place
low place
low place
6,427th place
low place
433rd place
766th place
1,173rd place
2,722nd place
754th place
3,840th place
574th place
6,850th place
5,543rd place
low place
1,142nd place
3,872nd place
543rd place
2,127th place
9,818th place
low place
low place
low place
low place
213th place
low place
low place
low place
low place
4,875th place
low place
768th place
1,728th place
117th place
405th place
3,706th place
low place
low place
low place
6,928th place
low place
48th place
247th place
1,326th place
7,066th place
965th place
1,417th place
9th place
18th place
low place
low place
low place
low place
1,226th place
800th place
20th place
48th place
3,491st place
low place
99th place
267th place
220th place
626th place
low place
low place
2,393rd place
974th place
703rd place
1,110th place
low place
low place
low place
low place
low place
low place
2,752nd place
low place
low place
low place
68th place
38th place
2,157th place
low place
low place
low place
low place
low place
low place
low place
2,665th place
low place
3,712th place
low place
low place
low place
1,512th place
9,417th place
3,391st place
9,073rd place
low place
low place
low place
low place
821st place
low place
1,625th place
low place
824th place
6,610th place
563rd place
low place
6,444th place
low place
low place
low place
9,779th place
low place
low place
low place
low place
low place
low place
low place
low place
low place
581st place
1,336th place
23rd place
106th place
765th place
2,794th place
1,127th place
low place
low place
low place
low place
low place
low place
low place
493rd place
4,356th place
low place
low place
low place
low place
4,375th place
3,332nd place
low place
low place
2,737th place
low place
low place
low place
818th place
2,583rd place
9,596th place
low place
2,371st place
low place
low place
low place
6,267th place
low place
low place
9,904th place
low place
low place
low place
low place
12th place
39th place
1,567th place
low place

24haubenin.info

  • Ayosso A. Deux ministres vaccinés contre Covid-19 [online]. 29 March 2021 [cit. 2021-03-30]. Dostupné online. (francouzsky) 

aa.com.tr

  • Aliyev J. Azerbaijan kicks off COVID-19 vaccination [online]. Anadolu Agency, 19 January 2021. Dostupné online. 
  • Turkish president gets COVID-19 vaccine. www.aa.com.tr. Anadolu Agency, 14 January 2021. Dostupné online [cit. 20 January 2021]. 

agenda.ge

  • Covid-19 vaccination with Sinovac to start on 24 May in Georgia [online]. [cit. 2021-05-21]. Dostupné online. 
  • One mln doses of Sinopharm, Sinovac now in Georgia - mass vaccination to start on July 5 [online]. [cit. 2021-07-03]. Dostupné online. 

akipress.com

  • Uzbekistan plans to obtain Sinovac coronavirus vaccine [online]. [cit. 2021-05-14]. Dostupné online. 

alkhaleejtoday.co

  • CoronaVac: Doses will come from China on nine flights and can... [online]. 1 November 2020 [cit. 2020-11-01]. Dostupné v archivu pořízeném z originálu dne 16 December 2020. (arabsky) 
  • Doria says it guarantees purchase of 100 million doses of CoronaVac... [online]. 29 October 2020 [cit. 2020-10-30]. Dostupné v archivu pořízeném z originálu dne 1 November 2020. (arabsky) 

ansa.it

  • Tunisia approva vaccino cinese Sinovac [online]. Agenzia Nazionale Stampa Associata (in Italian), 5 March 2021 [cit. 2021-03-07]. Dostupné online. (italsky) 

antaranews.com

en.antaranews.com

  • Bagus AR, Nasution R. 248 volunteers have received Sinovac vaccine injections in Bandung [online]. Redakce Assegaf F. [cit. 2020-09-22]. Dostupné v archivu pořízeném z originálu dne 30 September 2020. 
  • Indonesia's Bio Farma Urged to Boost Covid-19 Vaccine Production Capacity [online]. 21 April 2021 [cit. 2021-05-07]. Dostupné online. 

apnews.com

  • New coronavirus vaccine trials start in Brazil [online]. 21 July 2020 [cit. 2020-10-07]. Dostupné online. 
  • Tarigan E, Milko V. Indonesia starts mass COVID vaccinations over vast territory [online]. 13 January 2021 [cit. 2021-01-15]. Dostupné online. 
  • Sinovac vaccine restores a Brazilian city to near normal [online]. 1 June 2021 [cit. 2021-06-02]. Dostupné online. 
  • Savarese M. New coronavirus vaccine trials start in Brazil. Associated Press. 21 July 2020. Dostupné v archivu pořízeném z originálu dne 13 August 2020. 
  • Hong Kong kicks off COVID-19 vaccinations with Sinovac jab [online]. 26 February 2021 [cit. 2021-03-07]. Dostupné online. 
  • Philippines receives COVID-19 vaccine after delays [online]. 28 February 2021 [cit. 2021-02-28]. Dostupné online. 
  • Testorides K. North Macedonia gets 500,000 doses of Sinovac vaccines [online]. 27 June 2021 [cit. 2021-06-30]. Dostupné online. (anglicky) 

arab.news

  • Egypt to produce up to 80 million Sinovac vaccine doses annually [online]. 8 April 2021 [cit. 2021-04-08]. Dostupné online. 
  • Virus vaccine waiting on Saudi 'green light' [online]. 31 October 2020 [cit. 2020-11-01]. Dostupné v archivu pořízeném z originálu dne 16 December 2020. 

armradio.am

ru.armradio.am

  • В Армению отправлена китайская вакцина от COVID-19 [online]. [cit. 2021-05-09]. Dostupné online. (rusky) 

asiatimes.com

  • Chen F. Brazil joins ranks of Chinese vaccine backers [online]. 24 December 2020 [cit. 2020-12-30]. Dostupné online. 

bangkokpost.com

  • Sinovac jab 'up to 91% effective' after double dose. Bangkok Post. Dostupné online [cit. 30 June 2021]. 
  • Bangkok Post Public Company Limited. 2 million more Sinovac doses arrive in Thailand. Bangkok Post. Dostupné online [cit. 24 June 2021]. 

barrons.com

  • AFP-Agence France Presse. Chile Approves Chinese Coronavirus Vaccine [online]. [cit. 2021-01-21]. Dostupné online. 

bbc.com

  • Tan Y. Covid: What do we know about China's coronavirus vaccines? [online]. 16 December 2020 [cit. 2020-12-18]. Dostupné online. 

bloomberg.com

  • Brazil Clears Sinovac Trial to Resume Two Days After Halting It. www.bloomberg.com. Bloomberg L.P., 11 November 2020. Dostupné v archivu pořízeném z originálu dne 11 November 2020. 

bmj.com

  • Ranzani OT, Hitchings MD, Dorion M, D'Agostini TL, Paula RC, Paula OF, Villela EF, Torres MS, Oliveira SB, Schulz W, Almiron M. Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study. BMJ. 2021-08-20, s. n2015. Dostupné online. ISSN 1756-1833. doi:10.1136/bmj.n2015. PMID 34417194. 

bnamericas.com

  • BNamericas - Uruguay prepares to launch COVID-19 vaccinat... [online]. [cit. 2021-03-01]. Dostupné online. 

bnnbloomberg.ca

  • Leite J, Romani A. Overall Efficacy of Sinovac Vaccine in Brazil Just Above 50%. BNN Bloomberg. 12 January 2021. Dostupné online. 

businesslive.co.za

  • Brazil finds Sinovac's vaccine efficacy well below earlier findings. BusinessDay. 12 January 2021. Dostupné online. 

businessnews.com.tn

  • La Tunisie réceptionne le don chinois de 200.000 doses de vaccins [online]. Dostupné online. 

caspiannews.com

  • Azerbaijan Administers over 2 Million Doses of COVID-19 Vaccines [online]. [cit. 2021-05-28]. Dostupné online. 

channelnewsasia.com

  • Guinea receives purchase of 300,000 Sinovac COVID-19 vaccines [online]. [cit. 2021-04-21]. Dostupné online. 

chilereports.cl

  • Chile initiates clinical study for COVID-19 vaccine [online]. 4 August 2020 [cit. 2021-04-09]. Dostupné v archivu pořízeném z originálu dne 11 October 2020. 
  • Fifth shipment with over two million Sinovac vaccines arrives to Chile [online]. [cit. 2021-03-12]. Dostupné online. 

clinicaltrials.gov

  • SINOVAC RESEARCH AND DEVELOPMENT CO., LTD. A Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅰ/Ⅱ Clinical Trial, to Evaluate the Safety and Immunogenicity of the SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18~59 Years. [s.l.]: [s.n.] Dostupné online. Submitted: April 14, 2020. 
  • SINOVAC RESEARCH AND DEVELOPMENT CO., LTD. A Randomized, Double-blind, Placebo-controlled Clinical Trial, to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cell), in Healthy Elderly Aged 60 Years and Above. [s.l.]: [s.n.] Dostupné online. Submitted: May 9, 2020. 
  • HEALTH INSTITUTES OF TURKEY. Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial For Evaluation of Efficacy and Safety of SARS-CoV-2 Vaccine (Vero Cell), Inactivated [online]. 8 October 2020 [cit. 2020-10-21]. Dostupné v archivu pořízeném z originálu dne 20 October 2020. 
  • Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults. clinicaltrials.gov. United States National Library of Medicine, 4 November 2020. Dostupné online [cit. 6 June 2021]. 
  • SINOVAC RESEARCH AND DEVELOPMENT CO., LTD. A Randomized, Double-Blinded, Placebo-Controlled, Phase Ⅰ/Ⅱ Clinical Trial, to Evaluate the Safety and Immunogenicity of the SARS-CoV-2 Inactivated Vaccine (Vero Cell) in Healthy Population Aged 3-17 Years. [s.l.]: [s.n.] Dostupné online. Submitted: September 15, 2020. 
  • Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents. clinicaltrials.gov. United States National Library of Medicine, 3 June 2021. Dostupné online [cit. 5 June 2021]. 
  • Efficacy, Immunogenicity and Safety of COVID-19 Vaccine, Inactivated in Children and Adolescents. clinicaltrials.gov. United States National Library of Medicine, 5 August 2021. Dostupné online [cit. 5 August 2021]. 
  • PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Multicenter, Phase 3, Randomized Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against SARS-CoV-2 Infection in Adults.. [s.l.]: [s.n.] Dostupné online. Submitted: November 20, 2020. 

cnbc.com

  • Brazil's health regulator says China's Sinovac can resume Covid-19 vaccine trial after suspension [online]. CNBC, 12 November 2020 [cit. 2020-11-17]. Dostupné v archivu pořízeném z originálu dne 13 November 2020. 

cnnbrasil.com.br

  • Costa A. Estudo clínico que comprova maior eficácia da Coronavac é enviado para Lancet. CNN Brasil. São Paulo: 11 April 2021. Dostupné online [cit. 12 April 2021]. (Portuguese) 

ctvnews.ca

  • Savarese M. Sinovac vaccine restores a Brazilian city to near normal [online]. 1 June 2021 [cit. 2021-06-02]. Dostupné online. 

dailysabah.com

  • Sinovac allows its COVID-19 vaccine to be made in Turkey. Daily Sabah. 12 May 2021. Dostupné online [cit. 12 May 2021]. 
  • Chinese COVID-19 vaccine to be free, 1st doses to be delivered soon: Turkey's health minister. Daily Sabah. 23 November 2020. Dostupné v archivu pořízeném z originálu dne 23 November 2020. 
  • Few virus infections reported among vaccinated people in Turkey [online]. 12 March 2021 [cit. 2021-03-12]. Dostupné online. 
  • Turkey donates COVID-19 vaccines to North Macedonia [online]. 9 June 2021 [cit. 2021-06-11]. Dostupné online. (anglicky) 
  • Anadolu Agency. Turkey sends Chinese COVID-19 vaccines to Bosnia-Herzegovina [online]. 28 March 2021 [cit. 2021-03-29]. Dostupné online. 

dailytimes.com.pk

  • Over 20 million doses of Covid-19 vaccines transported from China to Pakistan [online]. 7 July 2021 [cit. 2021-07-07]. Dostupné online. (anglicky) 

dhakatribune.com

  • Bangladesh approves Sinovac Covid-19 vaccine for emergency use [online]. Dhaka Tribune, 6 June 2021 [cit. 2021-06-06]. Dostupné online. 

doi.org

  • Jara A, Undurraga EA, González C, Paredes F, Fontecilla T, Jara G, Pizarro A, Acevedo J, Leo K, Leon F, Sans C, Leighton P, Suárez P, García-Escorza H, Araos R. Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile. The New England Journal of Medicine. September 2021, s. 875–884. doi:10.1056/NEJMoa2107715. PMID 34233097. 
  • Tanriover MD, Doğanay HL, Akova M, Güner HR, Azap A, Akhan S, Köse Ş, Erdinç FŞ, Akalın EH, Tabak ÖF, Pullukçu H, Batum Ö, Yavuz SS, Turhan Ö, Yıldırmak MT, Köksal İ, Taşova Y, Korten V, Yılmaz G, Çelen MK, Altın S, Çelik İ, Bayındır Y, Karaoğlan İ, Yılmaz A, Özkul A, Gür H, Unal S, Kayaaslan B, Hasanoğlu İ, Dalkıran A, Aydos Ö, Çınar G, Akdemir-Kalkan İ, İnkaya AÇ, Aydin M, Çakir H, Yıldız J, Kocabıyık Ö, Arslan S, Nallı B, Demir Ö, Singil S, Ataman-Hatipoğlu Ç, Tuncer-Ertem G, Kınıklı S, Önal U, Mete B, Dalgan G, Taşbakan M, Yamazhan T, Kömürcüoğlu B, Yalnız E, Benli A, Keskin-Sarıtaş Ç, Ertosun MG, Özkan Ö, Emre S, Arıca S, Kuşçu F, Candevir A, Ertürk-Şengel B, Ayvaz F, Aksoy F, Mermutluoğlu Ç, Demir Y, Günlüoğlu G, Tural-Önür S, Kılıç-Toker A, Eren E, Otlu B, Mete AÖ, Koçak K, Ateş H, Koca-Kalkan İ, Aksu K. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. The Lancet. 8 July 2021, s. 213–222. ISSN 0140-6736. doi:10.1016/S0140-6736(21)01429-X. PMID 34246358. S2CID 235770533. (English) 
  • MALLAPATY, Smriti. China’s COVID vaccines have been crucial — now immunity is waning. Nature. 2021-10-14, s. 398–399. Dostupné online. doi:10.1038/d41586-021-02796-w. 
  • Hitchings MD, Ranzani OT, Torres MS, Oliveira SB, Almiron M, Said R, Borg R, Schulz WL, Oliveira RD, Silva PV, Castro DB. Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study. medRxiv. Findings; Early at-least-one-dose analysis: 24 June 2021. Dostupné online. doi:10.1101/2021.04.07.21255081. S2CID 233171896. 
  • Krause P, Fleming TR, Longini I, Henao-Restrepo AM, Peto R, Dean NE, Halloran ME, Huang Y, Fleming TR, Gilbert PB, DeGruttola V. COVID-19 vaccine trials should seek worthwhile efficacy. The Lancet. 12 September 2020, s. 741–743. ISSN 0140-6736. doi:10.1016/S0140-6736(20)31821-3. PMID 32861315. 
  • Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, Subbarao K, Kent SJ, Triccas JA, Davenport MP. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nature Medicine. Figure 3: May 2021, s. 1205–1211. Dostupné online. ISSN 1546-170X. doi:10.1038/s41591-021-01377-8. PMID 34002089. S2CID 234769053. 
  • Cerqueira-Silva T, Oliveira VA, Pescarini J, Júnior JB, Machado TM, Ortiz RF, Penna G, Ichihara MY, Barros JV, Boaventura V, Barreto ML. The effectiveness of Vaxzevria and CoronaVac vaccines: A nationwide longitudinal retrospective study of 61 million Brazilians (VigiVac-COVID19). medRxiv. Results, table S2: 25 August 2021, s. 2021.08.21.21261501. Dostupné online. doi:10.1101/2021.08.21.21261501. S2CID 237292831. 
  • Ranzani OT, Hitchings MD, Dorion M, D'Agostini TL, Paula RC, Paula OF, Villela EF, Torres MS, Oliveira SB, Schulz W, Almiron M. Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study. BMJ. 2021-08-20, s. n2015. Dostupné online. ISSN 1756-1833. doi:10.1136/bmj.n2015. PMID 34417194. 
  • Pan H, Wu Q, Zeng G, Yang J, Jiang D, Deng X, Chu K, Zheng W, Zhu F, Yu H, Yin W. Immunogenicity and safety of a third dose, and immune persistence of CoronaVac vaccine in healthy adults aged 18-59 years: interim results from a double-blind, randomized, placebo-controlled phase 2 clinical trial. medRxiv. 25 July 2021. Dostupné online. doi:10.1101/2021.07.23.21261026. S2CID 236321591. 
  • Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, Han W, Chen Z, Tang R, Yin W, Chen X, Hu Y, Liu X, Jiang C, Li J, Yang M, Song Y, Wang X, Gao Q, Zhu F. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. The Lancet. Infectious Diseases. February 2021, s. 181–192. doi:10.1016/S1473-3099(20)30843-4. PMID 33217362. 
  • Wu Z, Hu Y, Xu M, Chen Z, Yang W, Jiang Z, Li M, Jin H, Cui G, Chen P, Wang L, Zhao G, Ding Y, Zhao Y, Yin W. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. The Lancet. Infectious Diseases. June 2021, s. 803–812. doi:10.1016/S1473-3099(20)30987-7. PMID 33548194. 
  • Palacios R, Patiño EG, de Oliveira Piorelli R, Conde MT, Batista AP, Zeng G, Xin Q, Kallas EG, Flores J, Ockenhouse CF, Gast C. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial. Trials. October 2020, s. 853. doi:10.1186/s13063-020-04775-4. PMID 33059771. 
  • Han B, Song Y, Li C, Yang W, Ma Q,, Jiang Z, Li M, Lian X, Jiao W, Wang L, Shu Q. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial. The Lancet Infectious Diseases. 28 June 2021. Dostupné online. ISSN 1473-3099. doi:10.1016/S1473-3099(21)00319-4. PMID 34197764. 
  • Palacios R, Batista AP, Albuquerque CS, Patiño EG, Santos JD, Tilli Reis Pessoa Conde M, Piorelli RD, Pereira Júnior LC, Raboni SM, Ramos F, Sierra Romero GA. Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV Study. SSRN. 14 April 2021. Dostupné online [cit. 9 May 2021]. doi:10.2139/ssrn.3822780. S2CID 234875399. 
  • Bueno SM, Abarca K, González PA, Gálvez NM, Soto JA, Duarte LF, Schultz BM, Pacheco GA, González LA, Vázquez Y, Rios M. Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy Chilean adults in a phase 3 clinical trial. medRxiv. 1 April 2021, s. 2021.03.31.21254494. Dostupné online. doi:10.1101/2021.03.31.21254494. S2CID 232448335. 
  • Moutinho S. Chinese COVID-19 vaccine maintains protection in variant-plagued Brazil. Science. April 2021. doi:10.1126/science.abi9414. 

dominicantoday.com

  • Merit Designs Consulting Group. With yesterday's batch China has shipped 7,818,000 doses [online]. [cit. 2021-06-24]. Dostupné online. (anglicky) 

ebc.com.br

agenciabrasil.ebc.com.br

  • Cruz EP. Estudos mostram eficácia da CoronaVac contra três variantes do vírus [online]. 10 March 2021 [cit. 2021-03-18]. Dostupné online. (portugalsky) 

elcomercio.com

  • A Ecuador llegaron 700 000 vacunas Sinovac contra el covid-19 [online]. [cit. 2021-04-11]. Dostupné online. 

europa.eu

ema.europa.eu

  • EMA starts rolling review of COVID-19 Vaccine (Vero Cell) Inactivated [online]. [cit. 2021-05-04]. Dostupné online. 

fancycomma.com

  • Parekh N. CoronaVac: A COVID-19 Vaccine Made From Inactivated SARS-CoV-2 Virus. fancycomma.com. 22 July 2020. Dostupné online [cit. 25 July 2020]. 

fbcnews.com.fj

  • China to donate Sinovac Vaccine to Fiji [online]. [cit. 2021-03-22]. Dostupné online. 

financialpost.com

  • Sao Paulo starts building production plant for China's Sinovac vaccine – governor. Financial Post. 9 November 2020. Dostupné v archivu pořízeném z originálu dne 29 November 2020. 

fortune.com

  • World's vaccine testing ground deems Chinese COVID candidate 'the safest, most promising' [online]. [cit. 2020-11-09]. Dostupné v archivu pořízeném z originálu dne 31 October 2020. 
  • McGregor G. Why did the efficacy of China's top vaccine drop from 78% to 50%? [online]. 13 January 2021 [cit. 2021-01-14]. Dostupné online. 

galencentre.org

codeblue.galencentre.org

  • Malaysia's NPRA Approves AstraZeneca, Sinovac Covid-19 Vaccines [online]. CodeBlue, 2 March 2021 [cit. 2021-03-02]. Dostupné online. 

gavi.org

  • Gavi signs agreements with Sinopharm and Sinovac for immediate supply to COVAX [online]. [cit. 2021-07-13]. Dostupné online. (anglicky) 

gmanetwork.com

  • Duque says deal sealed for 25M doses of Sinovac COVID-19 vaccine [online]. [cit. 2021-01-10]. Dostupné online. 

go.com

abcnews.go.com

  • Semini L. Albania starts mass COVID vaccinations before tourist season [online]. [cit. 2021-03-28]. Dostupné online. 

gob.cl

  • Government meets with Sinovac for first COVID-19 vaccine clinical trial in Chile [online]. Government of Chile, 13 October 2020 [cit. 2020-11-08]. Dostupné v archivu pořízeném z originálu dne 17 October 2020. 

gov.cz

covid.gov.cz

  • Informace o dostupných vakcínách · Covid Portál. Covid Portál [online]. [cit. 2021-11-30]. Dostupné online. 

gov.sg

  • Sinovac-CoronaVac included in the National Vaccination Programme. www.gov.sg. Government of Singapore, 23 October 2021. Dostupné online [cit. 11 November 2021]. 

gub.uy

  • Segundo estudio de efectividad de vacunación anti SARS-CoV-2 en Uruguay al 8 de junio de 2021. www.gub.uy. 8 June 2021. Dostupné online. (španělsky) 

gulfnews.com

  • Egypt approves Sinovac COVID-19 vaccine for emergency use [online]. [cit. 2021-04-27]. Dostupné online. 

healthresearch.ph

registry.healthresearch.ph

  • A Multi-center, Randomized, Double-blind, Placebo-controlled Phase II/III Clinical Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 Inactivated (Vero Cell) Vaccine in the Elderly 60–80 Years of Age, Coronovac ENCOV19 Study [online]. Philippine Health Research Registry [cit. 2021-04-23]. Dostupné online. 

herald.co.zw

  • Zinyuke R. Zim receives 1 million Sinovac doses [online]. [cit. 2021-03-30]. Dostupné online. 

hornobserver.com

  • Somalia receives 200,000 Sinovac COVID-19 vaccine [online]. 11 April 2021 [cit. 2021-04-11]. Dostupné online. 

info.gov.hk

  • Government announces latest development of COVID-19 vaccine procurement (Hong Kong Government Press Releases) [online]. Hong Kong Government, 12 December 2020. Dostupné v archivu pořízeném z originálu dne 11 December 2020. 

jakartaglobe.id

  • Sinovac Vaccine Protects Health Workers From Severe Covid-19 in Delta-Hit Kudus. Jakarta Globe. 20 June 2021. Dostupné online [cit. 25 June 2021]. 

khmertimeskh.com

  • Health Ministry to start rolling out Sinovac vaccine tomorrow - Khmer Times [online]. 31 March 2021 [cit. 2021-03-31]. Dostupné online. 
  • Cambodia calls for 21-day interval between first and second doses for Sinopharm and Sinovac Covid-19 vaccines - Khmer Times [online]. 14 July 2021 [cit. 2021-07-30]. Dostupné online. (anglicky) 

kt.kz

  • В Казахстан доставили первую партию китайской вакцины CoronaVac | Kazakhstan Today [online]. [cit. 2021-06-07]. Dostupné online. (rusky) 

laprensagrafica.com

  • Llegan a El Salvador un millón de dosis de la vacuna china CoronaVac contra el covid-19 de la farmacéutica Sinovac [online]. [cit. 2021-03-28]. Dostupné online. (španělsky) 

libyaherald.com

  • Zaptia S. 150,000 doses of Chinese Sinovac anti-Coronavirus vaccines arrive from Turkey [online]. 15 April 2021 [cit. 2021-04-15]. Dostupné online. 

malaymail.com

  • Choong J. Health Ministry: Malaysia secures 18.4 million doses of Russian, Chinese Covid-19 vaccines [online]. The Malay Mail, 26 January 2021 [cit. 2021-01-26]. Dostupné online. 

medrxiv.org

  • Hitchings MD, Ranzani OT, Torres MS, Oliveira SB, Almiron M, Said R, Borg R, Schulz WL, Oliveira RD, Silva PV, Castro DB. Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study. medRxiv. Findings; Early at-least-one-dose analysis: 24 June 2021. Dostupné online. doi:10.1101/2021.04.07.21255081. S2CID 233171896. 
  • Cerqueira-Silva T, Oliveira VA, Pescarini J, Júnior JB, Machado TM, Ortiz RF, Penna G, Ichihara MY, Barros JV, Boaventura V, Barreto ML. The effectiveness of Vaxzevria and CoronaVac vaccines: A nationwide longitudinal retrospective study of 61 million Brazilians (VigiVac-COVID19). medRxiv. Results, table S2: 25 August 2021, s. 2021.08.21.21261501. Dostupné online. doi:10.1101/2021.08.21.21261501. S2CID 237292831. 
  • Pan H, Wu Q, Zeng G, Yang J, Jiang D, Deng X, Chu K, Zheng W, Zhu F, Yu H, Yin W. Immunogenicity and safety of a third dose, and immune persistence of CoronaVac vaccine in healthy adults aged 18-59 years: interim results from a double-blind, randomized, placebo-controlled phase 2 clinical trial. medRxiv. 25 July 2021. Dostupné online. doi:10.1101/2021.07.23.21261026. S2CID 236321591. 
  • Bueno SM, Abarca K, González PA, Gálvez NM, Soto JA, Duarte LF, Schultz BM, Pacheco GA, González LA, Vázquez Y, Rios M. Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy Chilean adults in a phase 3 clinical trial. medRxiv. 1 April 2021, s. 2021.03.31.21254494. Dostupné online. doi:10.1101/2021.03.31.21254494. S2CID 232448335. 

menafn.com

  • MENAFN. Colombia declares emergency use of Sinovac vaccines [online]. [cit. 2021-02-04]. Dostupné online. 

mercopress.com

en.mercopress.com

  • Uruguay will receive first batches of Pfizer and Sinovac vaccines late February or early March: US$ 120 million investment [online]. [cit. 2021-01-24]. Dostupné online. 

minsal.cl

  • Ministry of Health of Chile: Chile realiza primer estudio a nivel mundial sobre uso de dosis de refuerzo en vacunas inactivadas: Aumenta efectividad en prevención y hospitalización por COVID-19, tisková zpráva, [cit. {{{accessdate}}}], Dostupné on-line.

msn.com

  • China Sinovac Shot Seen Highly Effective in Real World Study. MSN. 12 May 2021. Dostupné online [cit. 12 May 2021]. 

mspbs.gov.py

  • CoronaVac, vacuna de alta eficacia [online]. Dostupné online. 

nationalpost.com

  • Ecuador signs agreement with Sinovac for 2 million COVID-19 vaccine: minister [online]. [cit. 2021-02-26]. Dostupné online. 

nature.com

  • MALLAPATY, Smriti. China’s COVID vaccines have been crucial — now immunity is waning. Nature. 2021-10-14, s. 398–399. Dostupné online. doi:10.1038/d41586-021-02796-w. 
  • Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, Subbarao K, Kent SJ, Triccas JA, Davenport MP. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nature Medicine. Figure 3: May 2021, s. 1205–1211. Dostupné online. ISSN 1546-170X. doi:10.1038/s41591-021-01377-8. PMID 34002089. S2CID 234769053. 
  • Mallapaty S. China's COVID vaccines are going global — but questions remain. Nature. 21 May 2021. Dostupné online. 

nih.gov

ncbi.nlm.nih.gov

  • Jara A, Undurraga EA, González C, Paredes F, Fontecilla T, Jara G, Pizarro A, Acevedo J, Leo K, Leon F, Sans C, Leighton P, Suárez P, García-Escorza H, Araos R. Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile. The New England Journal of Medicine. September 2021, s. 875–884. doi:10.1056/NEJMoa2107715. PMID 34233097. 
  • Tanriover MD, Doğanay HL, Akova M, Güner HR, Azap A, Akhan S, Köse Ş, Erdinç FŞ, Akalın EH, Tabak ÖF, Pullukçu H, Batum Ö, Yavuz SS, Turhan Ö, Yıldırmak MT, Köksal İ, Taşova Y, Korten V, Yılmaz G, Çelen MK, Altın S, Çelik İ, Bayındır Y, Karaoğlan İ, Yılmaz A, Özkul A, Gür H, Unal S, Kayaaslan B, Hasanoğlu İ, Dalkıran A, Aydos Ö, Çınar G, Akdemir-Kalkan İ, İnkaya AÇ, Aydin M, Çakir H, Yıldız J, Kocabıyık Ö, Arslan S, Nallı B, Demir Ö, Singil S, Ataman-Hatipoğlu Ç, Tuncer-Ertem G, Kınıklı S, Önal U, Mete B, Dalgan G, Taşbakan M, Yamazhan T, Kömürcüoğlu B, Yalnız E, Benli A, Keskin-Sarıtaş Ç, Ertosun MG, Özkan Ö, Emre S, Arıca S, Kuşçu F, Candevir A, Ertürk-Şengel B, Ayvaz F, Aksoy F, Mermutluoğlu Ç, Demir Y, Günlüoğlu G, Tural-Önür S, Kılıç-Toker A, Eren E, Otlu B, Mete AÖ, Koçak K, Ateş H, Koca-Kalkan İ, Aksu K. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. The Lancet. 8 July 2021, s. 213–222. ISSN 0140-6736. doi:10.1016/S0140-6736(21)01429-X. PMID 34246358. S2CID 235770533. (English) 
  • Krause P, Fleming TR, Longini I, Henao-Restrepo AM, Peto R, Dean NE, Halloran ME, Huang Y, Fleming TR, Gilbert PB, DeGruttola V. COVID-19 vaccine trials should seek worthwhile efficacy. The Lancet. 12 September 2020, s. 741–743. ISSN 0140-6736. doi:10.1016/S0140-6736(20)31821-3. PMID 32861315. 
  • Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, Subbarao K, Kent SJ, Triccas JA, Davenport MP. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nature Medicine. Figure 3: May 2021, s. 1205–1211. Dostupné online. ISSN 1546-170X. doi:10.1038/s41591-021-01377-8. PMID 34002089. S2CID 234769053. 
  • Ranzani OT, Hitchings MD, Dorion M, D'Agostini TL, Paula RC, Paula OF, Villela EF, Torres MS, Oliveira SB, Schulz W, Almiron M. Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study. BMJ. 2021-08-20, s. n2015. Dostupné online. ISSN 1756-1833. doi:10.1136/bmj.n2015. PMID 34417194. 
  • Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, Han W, Chen Z, Tang R, Yin W, Chen X, Hu Y, Liu X, Jiang C, Li J, Yang M, Song Y, Wang X, Gao Q, Zhu F. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. The Lancet. Infectious Diseases. February 2021, s. 181–192. doi:10.1016/S1473-3099(20)30843-4. PMID 33217362. 
  • Wu Z, Hu Y, Xu M, Chen Z, Yang W, Jiang Z, Li M, Jin H, Cui G, Chen P, Wang L, Zhao G, Ding Y, Zhao Y, Yin W. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. The Lancet. Infectious Diseases. June 2021, s. 803–812. doi:10.1016/S1473-3099(20)30987-7. PMID 33548194. 
  • Palacios R, Patiño EG, de Oliveira Piorelli R, Conde MT, Batista AP, Zeng G, Xin Q, Kallas EG, Flores J, Ockenhouse CF, Gast C. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial. Trials. October 2020, s. 853. doi:10.1186/s13063-020-04775-4. PMID 33059771. 
  • Han B, Song Y, Li C, Yang W, Ma Q,, Jiang Z, Li M, Lian X, Jiao W, Wang L, Shu Q. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial. The Lancet Infectious Diseases. 28 June 2021. Dostupné online. ISSN 1473-3099. doi:10.1016/S1473-3099(21)00319-4. PMID 34197764. 

nst.com.my

  • Babulal V. KJ gets first dose of Sinovac vaccine [NSTTV] [online]. 18 March 2021 [cit. 2021-03-19]. Dostupné online. 

nytimes.com

  • Corum J, Zimmer C. How the Sinovac Vaccine Works. The New York Times. Dostupné online [cit. 1 March 2021]. ISSN 0362-4331. 
  • Zimmer C, Corum J, Wee SL. Coronavirus Vaccine Tracker. The New York Times. Dostupné online [cit. 9 April 2021]. ISSN 0362-4331. 
  • Corum J, Zimmer C. How the Sinovac Vaccine Works. The New York Times. 26 April 2021. Dostupné online [cit. 29 April 2021]. ISSN 0362-4331. 

omanobserver.om

  • Oman receives Sinovac vaccines from China [online]. 17 May 2021 [cit. 2021-05-17]. Dostupné online. 

p4h.world

  • Vaccination against COVID-19 in Tajikistan: the role of joint efforts | P4H Network [online]. [cit. 2021-06-03]. Dostupné online. 

philstar.com

  • Cabico GK. 1M more Sinovac COVID-19 jabs arrive in Philippines [online]. [cit. 2021-06-11]. Dostupné online. 

primicias.ec

  • Ecuador recibe primeras 300.000 vacunas de Sinovac para ampliar inmunización [online]. [cit. 2021-04-11]. Dostupné online. (španělsky) 

ptvnews.ph

  • DOH eyes 5 hospitals for Sinovac vaccine Phase 3 clinical trial. PTV News. 16 September 2020. Dostupné online [cit. 7 October 2020]. 

r7.com

noticias.r7.com

  • Covid: 70% dos brasileiros não fazem questão de escolher vacina. R7.com. 3 March 2021. Dostupné online [cit. 9 March 2021]. (Portuguese) 

reuters.com

  • Liu R. China Sinovac says it reached two billion doses annual capacity for COVID-19 vaccine. Reuters. 2 April 2021. Dostupné online [cit. 2 April 2021]. 
  • Mano A, Simões E. Chinese vaccine draws demand across Latin America, say Brazilian officials. Reuters. 10 December 2020. Dostupné v archivu pořízeném z originálu dne 10 December 2020. 
  • UPDATE 2-Hungarian vaccine plant to be fitted for production of Chinese Sinopharm shots -minister. Reuters. 31 May 2021. Dostupné online [cit. 7 June 2021]. 
  • Nebehay S. WHO approves Sinovac COVID vaccine, the second Chinese-made dose listed. Reuters. Geneva: 1 June 2021. Dostupné online [cit. 1 June 2021]. 
  • Chinese drugmakers agree to supply more than half a billion vaccines to COVAX [online]. 12 July 2021 [cit. 2021-07-13]. Dostupné online. 
  • Chilean Sinovac trial leaders recommend third dose of COVID-19 vaccine. Reuters. Santiago: 15 July 2021. Dostupné online [cit. 19 July 2021]. 
  • Mass vaccination creates healthy oasis in Brazilian city [online]. 31 May 2021 [cit. 2021-06-02]. Dostupné online. 
  • Chile to give COVID-19 vaccine boosters for those inoculated with Sinovac. Reuters. 5 August 2021. Dostupné online [cit. 11 August 2021]. 
  • STAFF. China's Sinovac coronavirus vaccine candidate appears safe, slightly weaker in elderly. Reuters. 7 September 2020. Dostupné v archivu pořízeném z originálu dne 7 October 2020. 
  • Egypt to start local production of Sinovac vaccine mid-June- minister [online]. 7 June 2021 [cit. 2021-07-07]. Dostupné online. 
  • Widianto S, Lamb K. Hundreds of vaccinated Indonesian health workers get COVID-19, dozens in hospital. Reuters. 18 June 2021. Dostupné v archivu pořízeném z originálu dne 20 June 2021. 
  • Liu R, Kim M. Sinovac's coronavirus vaccine candidate approved for emergency use in China – source. Redakce Nicolaci da Costa A. Reuters. 29 August 2020. Dostupné v archivu pořízeném z originálu dne 31 August 2020. 
  • Moreno E. Panama approves use of China's Sinovac vaccine against COVID-19. Reuters. 9 April 2021. Dostupné online [cit. 10 April 2021]. 
  • Chinese drugmakers agree to supply more than half a billion vaccines to COVAX [online]. 12 July 2021 [cit. 2021-07-13]. Dostupné online. 
  • Turkey signs 50 million dose COVID-19 vaccine deal, health minister says. Reuters. 25 November 2020. Dostupné v archivu pořízeném z originálu dne 1 December 2020. 
  • Turkey grants emergency authorization to Sinovac's CoronaVac: Anadolu [online]. 13 January 2021 [cit. 2021-01-15]. Dostupné online. 
  • Thailand gives emergency use authorisation for Sinovac's COVID-19 vaccine – official. Reuters. 22 February 2021. Dostupné online [cit. 23 February 2021]. 
  • South Africa approves China's Sinovac COVID-19 vaccine - health ministry [online]. 3 July 2021 [cit. 2021-07-03]. Dostupné online. 
  • Dzirutwe M. Zimbabwe authorises Sputnik V, Sinovac coronavirus vaccines for emergency use. Reuters. 10 March 2021. Dostupné online [cit. 13 March 2021]. 
  • Reuters Staff. Albania gets 192,000 doses of Chinese Sinovac vaccine. Reuters. 25 March 2021. Dostupné online [cit. 28 March 2021]. 
  • Zinets N. Ukraine approves China's Sinovac COVID-19 vaccine [online]. 9 March 2021 [cit. 2021-03-10]. Dostupné online. 
  • Tanas A. Moldova to buy 400,000 doses of Sinovac COVID-19 vaccine. Reuters. 9 April 2021. Dostupné online [cit. 9 April 2021]. 
  • Simoes E. Brazil's Sao Paulo signs agreement with Sinovac for COVID vaccine doses. Reuters. 30 September 2020. Dostupné v archivu pořízeném z originálu dne 1 October 2020. 
  • McGeever J, Fonseca P. Brazil clears emergency use of Sinovac, AstraZeneca vaccines, shots begin. Reuters. 17 January 2021. Dostupné online [cit. 17 January 2021]. 
  • Colombia extends health state of emergency, seeks more Sinovac vaccines. Reuters. Dostupné online [cit. 26 February 2021]. 
  • Valencia A. Chile donates 40,000 doses of Sinovac vaccine to Ecuador and Paraguay. Reuters. 7 March 2021. Dostupné online [cit. 7 March 2021]. 
  • Mexico approves China's CanSino and Sinovac COVID-19 vaccines. Reuters. 11 February 2021. Dostupné online [cit. 11 February 2021]. 
  • Jorgic D. Mexico leans on China after Biden rules out vaccines sharing in short term. Reuters. 10 March 2021. Dostupné online [cit. 10 March 2021]. 
  • Boadle A. Brazil senators say anti-China views hurt access to COVID-19 vaccines. Reuters. 18 May 2021. Dostupné online [cit. 26 May 2021]. 
  • Fonseca P. Brazil institute says CoronaVac efficacy above 50%, but delays full results. Reuters. 24 December 2020. Dostupné online [cit. 25 December 2020]. 

riotimesonline.com

  • Fonseca I. CoronaVac May Be Four Times More Costly Than Flu Vaccine [online]. 30 October 2020 [cit. 2020-10-30]. Dostupné v archivu pořízeném z originálu dne 3 November 2020. 
  • Cardin A. 1.5 million Coronavac doses delivered to Brazilian government by Butantan [online]. 12 April 2021 [cit. 2021-04-17]. Dostupné online. 

sciencemediacentre.org

  • expert reaction to reported results of the Sinovac COVID-19 vaccine from a trial by the Butantan Institute in Brazil [online]. Science Media Centre, 12 January 2021. Dostupné v archivu pořízeném z originálu dne 14 June 2021. 

scmp.com

  • China approves Sinovac vaccines for general public use [online]. 6 February 2021 [cit. 2021-02-06]. Dostupné online. 
  • Sinovac is world's most used vaccine, but how good is its Delta protection? [online]. 8 July 2021 [cit. 2021-07-29]. Dostupné online. (anglicky) 
  • Baptista E. China-made coronavirus vaccine at heart of political showdown in Brazil [online]. 11 December 2020 [cit. 2021-01-18]. Dostupné online. 

semanticscholar.org

api.semanticscholar.org

  • Tanriover MD, Doğanay HL, Akova M, Güner HR, Azap A, Akhan S, Köse Ş, Erdinç FŞ, Akalın EH, Tabak ÖF, Pullukçu H, Batum Ö, Yavuz SS, Turhan Ö, Yıldırmak MT, Köksal İ, Taşova Y, Korten V, Yılmaz G, Çelen MK, Altın S, Çelik İ, Bayındır Y, Karaoğlan İ, Yılmaz A, Özkul A, Gür H, Unal S, Kayaaslan B, Hasanoğlu İ, Dalkıran A, Aydos Ö, Çınar G, Akdemir-Kalkan İ, İnkaya AÇ, Aydin M, Çakir H, Yıldız J, Kocabıyık Ö, Arslan S, Nallı B, Demir Ö, Singil S, Ataman-Hatipoğlu Ç, Tuncer-Ertem G, Kınıklı S, Önal U, Mete B, Dalgan G, Taşbakan M, Yamazhan T, Kömürcüoğlu B, Yalnız E, Benli A, Keskin-Sarıtaş Ç, Ertosun MG, Özkan Ö, Emre S, Arıca S, Kuşçu F, Candevir A, Ertürk-Şengel B, Ayvaz F, Aksoy F, Mermutluoğlu Ç, Demir Y, Günlüoğlu G, Tural-Önür S, Kılıç-Toker A, Eren E, Otlu B, Mete AÖ, Koçak K, Ateş H, Koca-Kalkan İ, Aksu K. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. The Lancet. 8 July 2021, s. 213–222. ISSN 0140-6736. doi:10.1016/S0140-6736(21)01429-X. PMID 34246358. S2CID 235770533. (English) 
  • Hitchings MD, Ranzani OT, Torres MS, Oliveira SB, Almiron M, Said R, Borg R, Schulz WL, Oliveira RD, Silva PV, Castro DB. Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study. medRxiv. Findings; Early at-least-one-dose analysis: 24 June 2021. Dostupné online. doi:10.1101/2021.04.07.21255081. S2CID 233171896. 
  • Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, Subbarao K, Kent SJ, Triccas JA, Davenport MP. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nature Medicine. Figure 3: May 2021, s. 1205–1211. Dostupné online. ISSN 1546-170X. doi:10.1038/s41591-021-01377-8. PMID 34002089. S2CID 234769053. 
  • Cerqueira-Silva T, Oliveira VA, Pescarini J, Júnior JB, Machado TM, Ortiz RF, Penna G, Ichihara MY, Barros JV, Boaventura V, Barreto ML. The effectiveness of Vaxzevria and CoronaVac vaccines: A nationwide longitudinal retrospective study of 61 million Brazilians (VigiVac-COVID19). medRxiv. Results, table S2: 25 August 2021, s. 2021.08.21.21261501. Dostupné online. doi:10.1101/2021.08.21.21261501. S2CID 237292831. 
  • Pan H, Wu Q, Zeng G, Yang J, Jiang D, Deng X, Chu K, Zheng W, Zhu F, Yu H, Yin W. Immunogenicity and safety of a third dose, and immune persistence of CoronaVac vaccine in healthy adults aged 18-59 years: interim results from a double-blind, randomized, placebo-controlled phase 2 clinical trial. medRxiv. 25 July 2021. Dostupné online. doi:10.1101/2021.07.23.21261026. S2CID 236321591. 
  • Palacios R, Batista AP, Albuquerque CS, Patiño EG, Santos JD, Tilli Reis Pessoa Conde M, Piorelli RD, Pereira Júnior LC, Raboni SM, Ramos F, Sierra Romero GA. Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV Study. SSRN. 14 April 2021. Dostupné online [cit. 9 May 2021]. doi:10.2139/ssrn.3822780. S2CID 234875399. 
  • Bueno SM, Abarca K, González PA, Gálvez NM, Soto JA, Duarte LF, Schultz BM, Pacheco GA, González LA, Vázquez Y, Rios M. Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy Chilean adults in a phase 3 clinical trial. medRxiv. 1 April 2021, s. 2021.03.31.21254494. Dostupné online. doi:10.1101/2021.03.31.21254494. S2CID 232448335. 

ssrn.com

  • Palacios R, Batista AP, Albuquerque CS, Patiño EG, Santos JD, Tilli Reis Pessoa Conde M, Piorelli RD, Pereira Júnior LC, Raboni SM, Ramos F, Sierra Romero GA. Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV Study. SSRN. 14 April 2021. Dostupné online [cit. 9 May 2021]. doi:10.2139/ssrn.3822780. S2CID 234875399. 

straitstimes.com

  • Soeriaatmadja W. Indonesia grants emergency use approval to Sinovac's vaccine, local trials show 65% efficacy. The Straits Times. 11 January 2021. Dostupné online [cit. 9 April 2021]. 
  • Goh T. MOH allows special access to Sinovac Covid-19 vaccine through private healthcare sector. The Straits Times. 2 June 2021. Dostupné online [cit. 3 June 2021]. (anglicky) 

tempo.co

en.tempo.co

  • Bhwana PG. Indonesian Ministry Review Says Sinovac 98% Effective to Prevent Covid Deaths [online]. 17 May 2021 [cit. 2021-05-20]. Dostupné online. 

tengrinews.kz

  • Китай отправит в Казахстан 3 миллиона доз вакцин от коронавируса [online]. 27 March 2021 [cit. 2021-06-07]. Dostupné online. (rusky) 

theaustralian.com.au

  • Indonesian Medics Find China Vaccine More Effective in Field. The Australian. 12 May 2021. Dostupné online [cit. 12 May 2021]. 

theguardian.com

  • Phillips T. Jair Bolsonaro claims 'victory' after suspension of Chinese vaccine trial [online]. 10 November 2020 [cit. 2021-01-18]. Dostupné online. 

thejakartapost.com

  • Sinovac vaccine has no critical side effects, BPOM says [online]. [cit. 2020-12-21]. Dostupné online. 
  • Indonesia receives 14 million Sinovac doses in 18th vaccine batch [online]. [cit. 2021-07-09]. Dostupné online. (anglicky) 

thelancet.com

  • Han B, Song Y, Li C, Yang W, Ma Q,, Jiang Z, Li M, Lian X, Jiao W, Wang L, Shu Q. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial. The Lancet Infectious Diseases. 28 June 2021. Dostupné online. ISSN 1473-3099. doi:10.1016/S1473-3099(21)00319-4. PMID 34197764. 

thenews.com.pk

  • DRAP allows emergency authorisation to fifth Covid-19 vaccine [online]. [cit. 2021-04-09]. Dostupné online. 

thestar.com.my

  • Cambodian PM okays two more Covid-19 vaccines - Sinovac and AstraZeneca - for emergency use [online]. [cit. 2021-03-19]. Dostupné online. 
  • Singapore receives China's Sinovac vaccine ahead of approval [online]. 25 February 2021 [cit. 2021-02-26]. Dostupné online. 

togofirst.com

  • First T. 200,000 doses of SINOVAC vaccines received [online]. [cit. 2021-04-27]. Dostupné online. 

trtworld.com

  • Turkey begins phase three trials of Chinese Covid-19 vaccine. TRT World News. 1 September 2020. Dostupné online [cit. 7 October 2020]. 

turkmenportal.com

  • В Туркменистан поступила крупная партия китайской вакцины «CoronaVac» | Здоровье [online]. Dostupné online. 

twitter.com

  • Djibouti Ministry of Health [online]. [cit. 2021-03-30]. Dostupné online. 

unian.info

covid.unian.info

  • Ukrainians vaccinated with CoronaVac to receive international vaccination certificate – minister [online]. [cit. 2021-06-03]. Dostupné online. (anglicky) 

uol.com.br

www1.folha.uol.com.br

  • Gielow I. Coronavac tem eficácia de 78% contra a Covid-19 em estudo no Brasil [online]. 7 January 2021 [cit. 2021-01-07]. Dostupné online. (portugalsky) 
  • Em meio a críticas por atrasos, Pazuello diz que Brasil está preparado para iniciar vacinação em janeiro [online]. 6 January 2021 [cit. 2021-01-07]. Dostupné online. (portugalsky) 
  • Carvalho D. 'Is 50% Good?', Asks Bolsonaro, Mocking Coronavac's Effectiveness [online]. 14 January 2021 [cit. 2021-01-18]. Dostupné online. 

noticias.uol.com.br

  • Bolívia autoriza uso de vacinas Sputnik V e CoronaVac contra covid-19 [online]. [cit. 2021-01-07]. Dostupné online. (portugalsky) 

vallartadaily.com

  • Mexico breaks new COVID-19 vaccination record [online]. 20 May 2021 [cit. 2021-05-25]. Dostupné online. 

visages-du-benin.com

  • Lutte contre la Covid-19 : 203.000 doses de vaccins s dont 100.000 offertes par la Chine au Bénin [online]. 23 March 2021 [cit. 2021-03-25]. Dostupné online. (francouzsky) 

voanews.com

  • Botswana Could Be First African Country to Vaccinate Entire Adult Population [online]. [cit. 2021-05-21]. Dostupné online. 

web.archive.org

  • Chile initiates clinical study for COVID-19 vaccine [online]. 4 August 2020 [cit. 2021-04-09]. Dostupné v archivu pořízeném z originálu dne 11 October 2020. 
  • Bagus AR, Nasution R. 248 volunteers have received Sinovac vaccine injections in Bandung [online]. Redakce Assegaf F. [cit. 2020-09-22]. Dostupné v archivu pořízeném z originálu dne 30 September 2020. 
  • CoronaVac: Doses will come from China on nine flights and can... [online]. 1 November 2020 [cit. 2020-11-01]. Dostupné v archivu pořízeném z originálu dne 16 December 2020. (arabsky) 
  • Mano A, Simões E. Chinese vaccine draws demand across Latin America, say Brazilian officials. Reuters. 10 December 2020. Dostupné v archivu pořízeném z originálu dne 10 December 2020. 
  • STAFF. China's Sinovac coronavirus vaccine candidate appears safe, slightly weaker in elderly. Reuters. 7 September 2020. Dostupné v archivu pořízeném z originálu dne 7 October 2020. 
  • Sao Paulo starts building production plant for China's Sinovac vaccine – governor. Financial Post. 9 November 2020. Dostupné v archivu pořízeném z originálu dne 29 November 2020. 
  • 'Fill and finish' Sinovac vaccine by Pharmaniaga approved [online]. 23 April 2021 [cit. 2021-11-26]. Dostupné v archivu pořízeném dne 2021-04-23. 
  • Savarese M. New coronavirus vaccine trials start in Brazil. Associated Press. 21 July 2020. Dostupné v archivu pořízeném z originálu dne 13 August 2020. 
  • World's vaccine testing ground deems Chinese COVID candidate 'the safest, most promising' [online]. [cit. 2020-11-09]. Dostupné v archivu pořízeném z originálu dne 31 October 2020. 
  • Doria says it guarantees purchase of 100 million doses of CoronaVac... [online]. 29 October 2020 [cit. 2020-10-30]. Dostupné v archivu pořízeném z originálu dne 1 November 2020. (arabsky) 
  • Brazil Clears Sinovac Trial to Resume Two Days After Halting It. www.bloomberg.com. Bloomberg L.P., 11 November 2020. Dostupné v archivu pořízeném z originálu dne 11 November 2020. 
  • Brazil's health regulator says China's Sinovac can resume Covid-19 vaccine trial after suspension [online]. CNBC, 12 November 2020 [cit. 2020-11-17]. Dostupné v archivu pořízeném z originálu dne 13 November 2020. 
  • HEALTH INSTITUTES OF TURKEY. Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial For Evaluation of Efficacy and Safety of SARS-CoV-2 Vaccine (Vero Cell), Inactivated [online]. 8 October 2020 [cit. 2020-10-21]. Dostupné v archivu pořízeném z originálu dne 20 October 2020. 
  • Chinese COVID-19 vaccine to be free, 1st doses to be delivered soon: Turkey's health minister. Daily Sabah. 23 November 2020. Dostupné v archivu pořízeném z originálu dne 23 November 2020. 
  • expert reaction to reported results of the Sinovac COVID-19 vaccine from a trial by the Butantan Institute in Brazil [online]. Science Media Centre, 12 January 2021. Dostupné v archivu pořízeném z originálu dne 14 June 2021. 
  • Widianto S, Lamb K. Hundreds of vaccinated Indonesian health workers get COVID-19, dozens in hospital. Reuters. 18 June 2021. Dostupné v archivu pořízeném z originálu dne 20 June 2021. 
  • Liu R, Kim M. Sinovac's coronavirus vaccine candidate approved for emergency use in China – source. Redakce Nicolaci da Costa A. Reuters. 29 August 2020. Dostupné v archivu pořízeném z originálu dne 31 August 2020. 
  • Virus vaccine waiting on Saudi 'green light' [online]. 31 October 2020 [cit. 2020-11-01]. Dostupné v archivu pořízeném z originálu dne 16 December 2020. 
  • Turkey signs 50 million dose COVID-19 vaccine deal, health minister says. Reuters. 25 November 2020. Dostupné v archivu pořízeném z originálu dne 1 December 2020. 
  • Government announces latest development of COVID-19 vaccine procurement (Hong Kong Government Press Releases) [online]. Hong Kong Government, 12 December 2020. Dostupné v archivu pořízeném z originálu dne 11 December 2020. 
  • More K. China delivers vaccine [online]. 26 April 2021 [cit. 2021-11-26]. Dostupné v archivu pořízeném dne 2021-04-30. 
  • Simoes E. Brazil's Sao Paulo signs agreement with Sinovac for COVID vaccine doses. Reuters. 30 September 2020. Dostupné v archivu pořízeném z originálu dne 1 October 2020. 
  • Fonseca I. CoronaVac May Be Four Times More Costly Than Flu Vaccine [online]. 30 October 2020 [cit. 2020-10-30]. Dostupné v archivu pořízeném z originálu dne 3 November 2020. 
  • Government meets with Sinovac for first COVID-19 vaccine clinical trial in Chile [online]. Government of Chile, 13 October 2020 [cit. 2020-11-08]. Dostupné v archivu pořízeném z originálu dne 17 October 2020. 

who.int

who.int

  • Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac. www.who.int [online]. [cit. 2021-11-30]. Dostupné online. (anglicky) 
  • {{{publisher}}}: WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations, tisková zpráva, [cit. {{{accessdate}}}], Dostupné on-line.

cdn.who.int

  • Evidence Assessment: Sinovac/CoronaVac COVID-19 vaccine. [s.l.]: World Health Organization, 29 April 2021. Dostupné online. 

worldcat.org

  • Corum J, Zimmer C. How the Sinovac Vaccine Works. The New York Times. Dostupné online [cit. 1 March 2021]. ISSN 0362-4331. 
  • Zimmer C, Corum J, Wee SL. Coronavirus Vaccine Tracker. The New York Times. Dostupné online [cit. 9 April 2021]. ISSN 0362-4331. 
  • Pearson S. Brazil's Experiment to Vaccinate Town With Chinese CoronaVac Reduced Covid-19 Deaths by 95%. The Wall Street Journal. 31 May 2021. Dostupné online [cit. 2 June 2021]. ISSN 0099-9660. 
  • Tanriover MD, Doğanay HL, Akova M, Güner HR, Azap A, Akhan S, Köse Ş, Erdinç FŞ, Akalın EH, Tabak ÖF, Pullukçu H, Batum Ö, Yavuz SS, Turhan Ö, Yıldırmak MT, Köksal İ, Taşova Y, Korten V, Yılmaz G, Çelen MK, Altın S, Çelik İ, Bayındır Y, Karaoğlan İ, Yılmaz A, Özkul A, Gür H, Unal S, Kayaaslan B, Hasanoğlu İ, Dalkıran A, Aydos Ö, Çınar G, Akdemir-Kalkan İ, İnkaya AÇ, Aydin M, Çakir H, Yıldız J, Kocabıyık Ö, Arslan S, Nallı B, Demir Ö, Singil S, Ataman-Hatipoğlu Ç, Tuncer-Ertem G, Kınıklı S, Önal U, Mete B, Dalgan G, Taşbakan M, Yamazhan T, Kömürcüoğlu B, Yalnız E, Benli A, Keskin-Sarıtaş Ç, Ertosun MG, Özkan Ö, Emre S, Arıca S, Kuşçu F, Candevir A, Ertürk-Şengel B, Ayvaz F, Aksoy F, Mermutluoğlu Ç, Demir Y, Günlüoğlu G, Tural-Önür S, Kılıç-Toker A, Eren E, Otlu B, Mete AÖ, Koçak K, Ateş H, Koca-Kalkan İ, Aksu K. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. The Lancet. 8 July 2021, s. 213–222. ISSN 0140-6736. doi:10.1016/S0140-6736(21)01429-X. PMID 34246358. S2CID 235770533. (English) 
  • Pearson S, Magalhaes L. Brazil Turns Sleepy Sugarcane Town Into Global Covid-19 Experiment. The Wall Street Journal. 18 February 2021. Dostupné online [cit. 2 June 2021]. ISSN 0099-9660. 
  • Krause P, Fleming TR, Longini I, Henao-Restrepo AM, Peto R, Dean NE, Halloran ME, Huang Y, Fleming TR, Gilbert PB, DeGruttola V. COVID-19 vaccine trials should seek worthwhile efficacy. The Lancet. 12 September 2020, s. 741–743. ISSN 0140-6736. doi:10.1016/S0140-6736(20)31821-3. PMID 32861315. 
  • Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, Subbarao K, Kent SJ, Triccas JA, Davenport MP. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nature Medicine. Figure 3: May 2021, s. 1205–1211. Dostupné online. ISSN 1546-170X. doi:10.1038/s41591-021-01377-8. PMID 34002089. S2CID 234769053. 
  • Ranzani OT, Hitchings MD, Dorion M, D'Agostini TL, Paula RC, Paula OF, Villela EF, Torres MS, Oliveira SB, Schulz W, Almiron M. Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study. BMJ. 2021-08-20, s. n2015. Dostupné online. ISSN 1756-1833. doi:10.1136/bmj.n2015. PMID 34417194. 
  • Corum J, Zimmer C. How the Sinovac Vaccine Works. The New York Times. 26 April 2021. Dostupné online [cit. 29 April 2021]. ISSN 0362-4331. 
  • Han B, Song Y, Li C, Yang W, Ma Q,, Jiang Z, Li M, Lian X, Jiao W, Wang L, Shu Q. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial. The Lancet Infectious Diseases. 28 June 2021. Dostupné online. ISSN 1473-3099. doi:10.1016/S1473-3099(21)00319-4. PMID 34197764. 

wsj.com

  • Pearson S. Brazil's Experiment to Vaccinate Town With Chinese CoronaVac Reduced Covid-19 Deaths by 95%. The Wall Street Journal. 31 May 2021. Dostupné online [cit. 2 June 2021]. ISSN 0099-9660. 
  • Pearson S, Magalhaes L. Brazil Turns Sleepy Sugarcane Town Into Global Covid-19 Experiment. The Wall Street Journal. 18 February 2021. Dostupné online [cit. 2 June 2021]. ISSN 0099-9660. 
  • Pearson S, Magalhaes L. Chinese Covid-19 Vaccine Is Far Less Effective Than Initially Touted in Brazil [online]. 12 January 2021 [cit. 2021-01-12]. Dostupné online. 

youtube.com

  • UPDATE VAKSINASI COVID-19: Efektivitas Vaksin SinoVac Terhadap Tenaga Kesehatan. www.youtube.com. 12 May 2021. Dostupné online. (indonésky)